Letter to the Editor
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment
Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab: comentario
Read
4119
Timeswas read the article
256
Total PDF
3863
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 April | 65 | 8 | 73 |
| 2024 March | 3392 | 32 | 3424 |
| 2024 February | 62 | 28 | 90 |
| 2024 January | 53 | 26 | 79 |
| 2023 December | 51 | 29 | 80 |
| 2023 November | 51 | 32 | 83 |
| 2023 October | 38 | 30 | 68 |
| 2023 September | 65 | 43 | 108 |
| 2023 August | 80 | 23 | 103 |
| 2023 March | 5 | 5 | 10 |
| 2022 August | 1 | 0 | 1 |
